Answers are grounded in this paper and cite their sources.
Prospective study reveals severe atherosclerotic cardiovascular disease risks in individuals with dysbetalipoproteinemia, highlighting remnant cholesterol metabolism.
Dysbetalipoproteinemia (DBL) is a disorder of remnant cholesterol metabolism associated with a severe risk of atherosclerotic cardiovascular disease (ASCVD).
No takes yet. Share an insight, caveat, or question.
Paquette et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: